WKL Wolters Kluwer NV

Researchers’ Predictive Algorithm to Forecast Coronavirus Outbreaks Taps Clinicians’ Searches in UpToDate from Wolters Kluwer

today announced that a new predictive algorithm is using search activity from clinicians at the point of care—together with data streams from social media, internet search trends and mobility data from smartphones—to serve as a coronavirus early-warning system that could forecast an outbreak two to three weeks in advance. The algorithm is presented in a pre-published paper on .

Researchers, including Dr. Mauricio Santillana, Director of the Machine Intelligence Lab, Boston Children’s Hospital, and an Assistant Professor of Pediatrics and Epidemiology at Harvard Medical School, used a complex prediction model developed by Northeastern University to analyze , as well as COVID-related Twitter posts that included geotag location information, Google searches on COVID topics, anonymous mobility data from smartphones, and temperature readings from the Kinsa Smart Thermometer app.

“UpToDate search data is an important part of this algorithm because it gives us insight into what information clinicians need right now,” said Dr. Santillana. “A COVID-19 early warning system that analyzes multiple data streams, including clinician searches at the point of care could help providers and public authorities to anticipate new epidemic waves and implement effective interventions.”

In order to test the ability of the algorithm to forecast COVID-19 outbreaks, researchers compared how each data stream correlated with case counts and deaths in each state in March and April. For example, an abrupt increase in tweets about COVID-19 appeared over a week before reported cases spiked dramatically in New York in the middle of March. Related Google searches and Kinsa temperature readings increased several days before the spike as well. The hybrid algorithm estimated outbreaks by an average of 21 days.

“COVID-19 created a global need for reliable information with unparalleled urgency. Our team responded by synthesizing evidence-based guidance that addressed the many complex and dynamic clinical questions facing healthcare professionals and patients,” said Peter Bonis, Chief Medical Officer for Clinical Effectiveness at Wolters Kluwer, Health. “Our COVID-19 topics have been viewed more than 10 million times by front-line providers around the world, and we are pleased that an added benefit from such information-seeking is the ability to track the pandemic.”

Read the full study .

Learn more about and the .

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

For more information about our Health solutions, visit and follow us on and Twitter .

For more information, visit , follow us on , , , and .

EN
29/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details December 11 – December 17, 2025

Share Buyback Transaction Details December 11 – December 17, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 11 – December 17, 2025 Alphen aan den Rijn – December 18, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 238,453 of its own ordinary shares in the period from December 11, 2025, up to and including December 17, 2025, for €21.4 million and at an average share price of €89.85. These repurchases are part of the share buyback...

 PRESS RELEASE

Share Buyback Transaction Details December 4 – December 10, 2025

Share Buyback Transaction Details December 4 – December 10, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 4 – December 10, 2025 Alphen aan den Rijn – December 11, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 209,603 of its own ordinary shares in the period from December 4, 2025, up to and including December 10, 2025, for €18.7 million and at an average share price of €89.33. These repurchases are part of the share buyback pr...

David Vagman ... (+5)
  • David Vagman
  • CFA
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Wolters Kluwer/AI winner at an attractive valuation/BUY

Our conviction in the Wolters Kluwer investment case remains high. Three positives stand out in our view. Firstly, current trading is solid, with 9M25 organic revenue growth beating expectations. Secondly, the company's expert curated (proprietary) content is a strong moat vs AI-only alternatives as the company operates in high-stake environments where reliability is key. Thirdly, valuation has become highly attractive. We slightly lower our target price to €160 per share (from €173). We keep ou...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch